SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): MAY 26, 2004
HALSEY DRUG CO., INC.
616 N. NORTH COURT, SUITE 120, PALATINE, ILLINOIS 60067
(847-705-7709)
Incorporated under the laws of Commission File Number I.R.S. Employer Identification Number
State of New York 1-10113 11-0853640
ITEM 5. OTHER EVENTS
On May 26, 2004, Halsey Drug Co., Inc. (the "Company") issued a
press release disclosing the filing of four non-provisional patent
applications with the US Patent and Trademark Office relating to the
Company's opioid synthesis technologies. A copy of the Company's press
release is attached as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(B) EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
------ -----------
99.1 Press Release of Halsey Drug Co., Inc. dated May 26, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HALSEY DRUG CO., INC.
By: /s/ Peter A. Clemens
-------------------------------------
Peter A. Clemens
Senior Vice President & Chief
Financial Officer
Date: May 26, 2004
3
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
99.1 Press Release dated May 26, 2004.
4